Didier Desmaële

10.1k total citations
207 papers, 8.0k citations indexed

About

Didier Desmaële is a scholar working on Molecular Biology, Organic Chemistry and Biomaterials. According to data from OpenAlex, Didier Desmaële has authored 207 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 72 papers in Organic Chemistry and 50 papers in Biomaterials. Recurrent topics in Didier Desmaële's work include Nanoparticle-Based Drug Delivery (47 papers), RNA Interference and Gene Delivery (42 papers) and Asymmetric Synthesis and Catalysis (22 papers). Didier Desmaële is often cited by papers focused on Nanoparticle-Based Drug Delivery (47 papers), RNA Interference and Gene Delivery (42 papers) and Asymmetric Synthesis and Catalysis (22 papers). Didier Desmaële collaborates with scholars based in France, United States and Italy. Didier Desmaële's co-authors include Patrick Couvreur, Jean d’Angelo, Fatima Zouhiri, Maria Teresa Peracchia, Ruxandra Gref, Jean‐François Mouscadet, L. Harivardhan Reddy, Sinda Lepêtre‐Mouelhi, Hélène Chacun and Dominique Georgin and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Nano Letters.

In The Last Decade

Didier Desmaële

203 papers receiving 7.8k citations

Peers

Countries citing papers authored by Didier Desmaële

Since Specialization

Citations

This map shows the geographic impact of Didier Desmaële's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Desmaële with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Desmaële more than expected).

Fields of papers citing papers by Didier Desmaële

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Desmaële. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Desmaële. The network helps show where Didier Desmaële may publish in the future.

Co-authorship network of co-authors of Didier Desmaële

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Desmaële. A scholar is included among the top collaborators of Didier Desmaële based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Desmaële. Didier Desmaële is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic potential of siRNA PMP22-SQ nanoparticles for Charcot-Marie-Tooth 1A neuropathy in rodents and non-human primates 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), Yosef Landesman, (unknown), Didier Desmaële, Françoise Piguet, Rafael Alonso, (unknown), David Adams, Charbel Massaad, Liliane Massaad-Massade	2
2	Impact of Rhenium(I)-Diselenoether Compound on Cell Adhesion, Migration, Invasion Capacities, and MMP-2 Release in MDA-MB-231 Breast Cancer Cells 2024 ·Anticancer Research ·(unknown), Didier Desmaële, (unknown), V. Veena	0
3	Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy 2023 ·Materials ·(unknown), Séverine Domenichini, Sandrine Zanna, Frédéric Gobeaux, Christophe Piesse, Didier Desmaële, Mariana Varna	1
4	Remarkable Effects of a Rhenium(I)-diselenoether Drug on the Production ofCathepsins B and S by Macrophages and their Polarizations 2023 ·Current Pharmaceutical Design ·Philippe Collery, Didier Desmaële, (unknown), V. Veena	3
5	Degradation of Polymer-Drug Conjugate Nanoparticles Based on Lactic and Itaconic Acid 2022 ·International Journal of Molecular Sciences ·(unknown), Mohamed Haouas, (unknown), Didier Desmaële, Charlotte Martineau, Ruxandra Gref	4
6	New Nanoparticle Formulation for Cyclosporin A: In Vitro Assessment 2021 ·Pharmaceutics ·(unknown), (unknown), Julie Laloy, Romain Brusini, (unknown), Frédéric Gobeaux, Valérie Nicolas, Pierre Chaminade, Sonia Abreu, Didier Desmaële, Mariana Varna	7
7	Supramolecular organization and biological interaction of squalenoyl siRNA nanoparticles 2021 ·International Journal of Pharmaceutics ·(unknown), Frédéric Gobeaux, Miryana Hémadi, (unknown), P. Guénoun, Didier Desmaële, Patrick Couvreur, Frank Wien, Fabienne Testard, Liliane Massaad-Massade	5
8	Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma 2020 ·Cancers ·Carlos Rodríguez‐Nogales, Haritz Moreno, Carolina Zandueta, Didier Desmaële, Fernando Lecanda, Patrick Couvreur, María J. Blanco‐Prieto	9
9	Vitamin C–squalene bioconjugate promotes epidermal thickening and collagen production in human skin 2020 ·Scientific Reports ·Ruxandra Gref, Claudine Deloménie, Andrei Maksimenko, Elodie Gouadon, (unknown), Elian Lati, Didier Desmaële, Fatima Zouhiri, Patrick Couvreur	61
10	Highly Porous Hybrid Metal–Organic Nanoparticles Loaded with Gemcitabine Monophosphate: a Multimodal Approach to Improve Chemo‐ and Radiotherapy 2019 ·ChemMedChem ·Xue Li, Erika Porcel, Mario Menéndez-Miranda, (unknown), Xiaomin Yang, Christian Serre, (unknown), Didier Desmaële, S. Lacombe, Ruxandra Gref	30
11	Design of Rhenium Compounds in Targeted Anticancer Therapeutics 2019 ·Current Pharmaceutical Design ·Philippe Collery, Didier Desmaële, V. Veena	63
12	A Squalene-Based Nanomedicine for Oral Treatment of Colon Cancer 2017 ·Cancer Research ·Larissa Kotelevets, Eric Chastre, Joachim Caron, Julie Mougin, Gérard Bastian, Alain Pineau, Francine Walker, Thérèse Lehy, Didier Desmaële, Patrick Couvreur	67
13	Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery 2017 ·Nature Communications ·(unknown), Simona Mura, Semen Yesylevskyy, (unknown), (unknown), Guillaume Bort, Julie Mougin, Didier Desmaële, Sinda Lepêtre‐Mouelhi, Grégory Pieters, Bohdan Andreiuk, Andrey S. Klymchenko, (unknown), Christophe Ramseyer, Patrick Couvreur	83
14	Turning Squalene into Cationic Lipid Allows a Delivery of siRNA in Cultured Cells 2015 ·Nucleic Acid Therapeutics ·Jean‐Rémi Bertrand, Claire Lucas, Ngoc Minh Pham, Catherine Pioche‐Durieu, Patrick Couvreur, Claude Malvy, Didier Desmaële	5
15	Osteotropic Polypeptide Nanoparticles with Dual hydroxyapatite Binding Properties and Controlled Cisplatin Delivery 2014 ·Pharmaceutical Research ·Laura de Miguel, Iuliana Popa, Magali Noiray, Éric Caudron, Ludovica Arpinati, Didier Desmaële, Gerardo Cebrián‐Torrejón, Antonio Doménech‐Carbó, Gilles Ponchel	5
16	Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations 2014 ·PLoS ONE ·(unknown), Giorgia Urbinati, Hubert Chapuis, Didier Desmaële, Jean‐Rémi Bertrand, Patrick Couvreur, Liliane Massaad-Massade	14
17	Effects of Silencing the RET/PTC1 Oncogene in Papillary Thyroid Carcinoma by siRNA-Squalene Nanoparticles With and Without Fusogenic Companion GALA-Cholesterol 2013 ·Thyroid ·(unknown), Andrei Maksimenko, Giorgia Urbinati, Hubert Chapuis, (unknown), Didier Desmaële, Yasuhiro Hayashi, Hideyoshi Harashima, Patrick Couvreur, Liliane Massaad-Massade	27
18	Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Fatima Zouhiri, Marie Normand‐Bayle, (unknown), Didier Desmaële, Hervé Leh, Jean‐François Mouscadet, Gladys Mbemba, (unknown), (unknown), Marc Le Bret, Jean d’Angelo	82
19	Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery 2001 ·Pharmaceutical Research ·Pilar Calvo, Bruno Gouritin, Hélène Chacun, Didier Desmaële, Jean d’Angelo, J. P. Noël, Dominique Georgin, Elias Fattal, J.P. Andreux, Patrick Couvreur	349
20	Stereochemical Aspects in the Asymmetric Michael Addition of Chiral Imines to Substituted Electrophilic Alkenes 1996 ·The Journal of Organic Chemistry ·Christian Cavé, Didier Desmaële, Jean d’Angelo, C. Riche, A. Chiaroni	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact